Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
9
result was found. Results that relate to
Valsartan
Application value of valsartan combined with Bailing capsule in the treatment of proteinuria patients with chronic nephritis
Published on
Journal of Mathematical Medicine
2023,36(3):208-214.
7758 times
1701 times
Xiao-Cao LYU
Gai LYU
Ti CAO
Bing LU
Chronic nephritis
Valsartan
Bailing capsule
Proteinuria
Renal function
Adverse reactions
Details
Cost-utility analysis of sacubitril/valsartan, dapagliflozin and empagliflozin in heart failure with reduced ejection fraction
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(8):878-885.
8331 times
1761 times
Dan-Dan LU
Sheng-Xiang WANG
Shan LU
Dan PAN
Li-Yuan SHI
Fei-Chuang Jing2
Heart failure with reduced ejection fraction
Sacubitril/
valsartan
Dapagliflozin
Empagliflozin
Markov model
Cost-utility analysis
Details
Efficacy and safety of sacubitril-valsartan in treating hypertension: a Meta-analysis
Published on
Journal of Mathematical Medicine
2023,36(11):829-837.
8983 times
2888 times
Xiao-Dong TAN
Yun DONG
Chen XU
Hong TANG
Sacubitril-
valsartan
Hypertension
Meta-analysis
Details
The effects of sacubitril-valsartan tablets on the expressions of NT-proBNP, cTnI and cardiac function in patients with chronic cardiac insufficiency
Published on
Frontiers in Pharmaceutical Sciences
2023,36(11):298-303.
5769 times
1359 times
Qiu-Shi WANG
Xiao-Ran LI
Yao YAO
Sacubitril-
valsartan
tablets
Chronic cardiac insufficiency
N terminal pro B type natriuretic peptide
Troponin I
Cardiac function
Details
Efficacy and safety of sacubitril/valsartan in the treatment of atrial fibrillation after ablation: a Meta-analysis
Published on
New Medicine
2024,34(8):916-926.
11012 times
2106 times
BI Longfei
LIU Yao
YU Dan
DAN Xuechuan
LI Kui
Sacubitril/
valsartan
Atrial fibrillation
Angiotensin converting enzyme inhibitors
Angiotensin receptor blockers
Ablation
Meta-analysis
Details
Efficacy and safety of dapagliflozin combined with sacubitril valsartan in the treatment of heart failure after acute myocardial infarction: a Meta-analysis
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(11):1254-1264.
10882 times
1937 times
BI Longfei
LIU Yao
LIU Bingxia
LI Kui
Dapgliflozin
Sacubitril
valsartan
Myocardial infarction
Heart failure
Meta-analysis
Systematic review
Randomized controlled trial
Details
A case report of acute kidney injury caused by semaglutide in combination with multiple medications
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(7):835-840.
9189 times
1215 times
GU Jiamei
TANG Chenquan
JIANG Yi
YIN Hao
FENG Chen
XUE Yi
Semaglutide
Metformin
Dapagliflozin
Sacubitril/
Valsartan
Acute kidney injury
Adverse reactions
Details
Application of valsartan in combination with amlodipine in adverse reactions in elderly patients with hypertension
Published on
Frontiers in Pharmaceutical Sciences
2025,29(11):1906-1913.
3394 times
550 times
ZHOU Yan
SU Fei
ZHU Junjun
LYU Xiongsheng
Valsartan
Amlodipine
Hypertension
Elderly
FAERS database
Adverse drug event
Rational drug use
Signal mining
Details
Patent technology analysis of angiotensin receptor-neprilysin inhibitor sacubitril valsartan
Published on
Frontiers in Pharmaceutical Sciences
2026,30(3):466-476.
416 times
132 times
GAN Yu
SHI Xiaorong
Sacubitril
valsartan
Entresto
Co-crystals
Patent technology analysis
Patent layout
Details